These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8729891)

  • 1. Hypersensitivity reactions to etoposide.
    Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH
    Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etoposide desensitization. A case report].
    Alvarez Cardona A; Hernández Nieto L; Pérez Gómez M; Pedroza Meléndez A; Huerta López JG
    Rev Alerg Mex; 2010; 57(1):33-6. PubMed ID: 20857627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide hypersensitivity.
    Yersal O; Barutca S; Meydan N
    J BUON; 2013; 18(2):547-8. PubMed ID: 23818380
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
    Pringle NR; Gilbar PJ; Grewal GD
    J Oncol Pharm Pract; 2022 Jun; 28(4):1019-1023. PubMed ID: 35037804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].
    Pantín C; Letellez J; Calzas J; Mohedano E
    Farm Hosp; 2018 Jan; 42(1):27-28. PubMed ID: 29306312
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of suspected immunologic-based hypersensitivity reactions to etoposide therapy.
    Kasperek C; Black CD
    Ann Pharmacother; 1992 Oct; 26(10):1227-30. PubMed ID: 1421643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient experiences adverse drug reaction to etoposide for adenocarcinoma of the lung.
    Ives RK
    Oncol Nurs Forum; 1995 Sep; 22(8):1289. PubMed ID: 8532560
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
    Hudson MM; Weinstein HJ; Donaldson SS; Greenwald C; Kun L; Tarbell NJ; Humphrey WA; Rupp C; Marina NM; Wilimas J
    J Clin Oncol; 1993 Jun; 11(6):1080-4. PubMed ID: 8501494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of pneumomediastinum during BEP (bleomycin, etoposide, cisplatin) chemotherapy for testicular cancer].
    Noguchi G; Ota J; Ishigaki H; Onuki T; Kato Y; Moriyama M
    Hinyokika Kiyo; 2013 Aug; 59(8):545-9. PubMed ID: 23995535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-step etoposide desensitization protocol: A pediatric, adolescent, and young adult case series.
    Stockton W; Lam F; Nguyen T; Nguyen T; Kirov I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28795. PubMed ID: 33155419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypersensitivity reaction to etoposide. A case report].
    Mullera Martí M; Riba Solé M; Fernández de Gamarra Martínez E; Mangues Bafalluy MA
    Farm Hosp; 2014 May; 38(3):255-6. PubMed ID: 24951914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful rapid desensitization to intravenous etoposide using a 14-step protocol.
    Garcia Escallon S; Muniyappa PK; Subramanian S
    J Allergy Clin Immunol Pract; 2015; 3(4):627-8. PubMed ID: 25634221
    [No Abstract]   [Full Text] [Related]  

  • 13. Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies.
    Stockton WM; Nguyen T; Zhang L; Dowling TC
    J Oncol Pharm Pract; 2020 Mar; 26(2):397-405. PubMed ID: 31315549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Collier K; Schink C; Young AM; How K; Seckl M; Savage P
    J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide-induced hypersensitivity reactions. Report of two cases.
    Tucci E; Pirtoli L
    Chemioterapia; 1985 Dec; 4(6):460-2. PubMed ID: 3830414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide.
    Ronsley R; Jacques L; Potts JE; Clement K; Dix DB; Mahon P
    Pediatr Hematol Oncol; 2021 Apr; 38(3):208-215. PubMed ID: 33150845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel.
    Cormio G; Di Vagno G; Melilli GA; Cazzolla A; Di Gesù G; Carriero C; Cramarossa D; Loverro G; Selvaggi L
    J Chemother; 1999 Oct; 11(5):407-9. PubMed ID: 10632389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions to etoposide. A report of three cases and review of the literature.
    de Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M
    Am J Clin Oncol; 1994 Oct; 17(5):387-9. PubMed ID: 8092107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
    Brooks JP; Azmy V; Thompson A; Luon D; Prozora SD; Price C; Hsu FI
    J Oncol Pharm Pract; 2020 Jan; 26(1):228-231. PubMed ID: 30885040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.